drugset / Trial / NCT02632994
Master Rollover Protocol for Continued Safety Assessment of Study Drug
Summary
This study is for patients who have participated in a previous study and who continue to receive benefit to have continued access to study drug and/or treatment.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY2503029 | Unknown | — | Oral |
| Subject | LY3838915 | Unknown | — | Oral |
| Subject | LY3847429 | Unknown | — | Oral |
| Subject | Samotolisib | Small molecule | — | Oral |